Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
- Conditions
- Health Condition 1: null- DyslipidemiaHealth Condition 2: E781- Pure hyperglyceridemia
- Registration Number
- CTRI/2013/02/003429
- Lead Sponsor
- Merck Sharp and Dohme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 850
Currently admitted with a confirmed diagnosis of first acute coronary event
(STEMI/NSTEMI/Unstable Angina).
- Access to medical records covering the entire study period, and availability of data
required for the study
- Potential to collect blood sample within 24 hours of onset for symptoms.
- Considered for initiation/maintenance/modification of statin therapy before discharge
from hospital.
- Willing to comply with the study requirements.
- Patients who are already participating in a clinical trial or any type of other clinical study involving therapeutic intervention or otherwise failing to consent to interview
- Patients with known inherited disorder of lipoprotein metabolism
- Patients with history of hypothyroidism, nephrotic syndrome, chronic alcoholism, Cushing syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method